Living with psoriasis: Prevalence of shame, anger, worry, and problems in daily activities and social life

Acta Dermato-Venereologica

Volumn 92, Issue 3, 2012, Pages 299-303

  Sampogna, Francesca ^a   Tabolli, Stefano ^a   Abeni, Damiano ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Anger; Psoriasis; Quality of life; Shame; Skindex 29; Worry

Indexed keywords

ACADEMIC ACHIEVEMENT; ADL DISABILITY; ADULT; ANGER; ANNOYANCE; ANXIETY; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENERAL HEALTH QUESTIONNAIRE 12; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUSTULOSIS PALMOPLANTARIS; QUALITY OF LIFE; SHAME; SKINDEX 29 QUESTIONNAIRE; SOCIAL LIFE; STRUCTURED QUESTIONNAIRE;

ANGER; ANXIETY; DEPRESSION; EDUCATIONAL STATUS; FEMALE; HOBBIES; HUMANS; INTERPERSONAL RELATIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SHAME; SOCIAL PARTICIPATION; WORK;

EID: 84859785434     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1273     Document Type: Article

References (39)

1. Augustin M, Kruger K, Radtke MA, Schwippl I, Reich K. Disease severity, quality of life and health care in plaquetype psoriasis: a multicenter cross-sectional study in Germany. Dermatology 2008; 216: 366-372.
2. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6: 383-392.
3. Sampogna F, Tabolli S, Soderfeldt B, Axtelius B, Aparo U, Abeni D. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006; 154: 844-849.
4. Sampogna F, Tabolli S, Abeni D. The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. Br J Dermatol 2007; 157: 508-513.
5. Schmid-Ott G, Kunsebeck HW, Jager B, Sittig U, Hofste N, Ott R, et al. Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol 2005; 85: 27-32.
6. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002; 47: 512-518.
7. Magin P, Adams J, Heading G, Pond D, Smith W. The psychological sequelae of psoriasis: results of a qualitative study. Psychol Health Med 2009; 14: 150-161.
8. Conrad R, Geiser F, Haidl G, Hutmacher M, Liedtke R, Wermter F. Relationship between anger and pruritus perception in patients with chronic idiopathic urticaria and psoriasis. J Eur Acad Dermatol Venereol 2008; 22: 1062-1069.
9. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol 2007; 57: 963-971.
10. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
11. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-1440.
12. Sampogna F, Raskovic D, Guerra L, Pedicelli C, Tabolli S, Leoni L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol 2008; 159: 351-359.
13. Sampogna F, Gisondi P, Tabolli S, Abeni D. Impairment of sexual life in patients with psoriasis. Dermatology 2007; 214: 144-150.
14. Sampogna F, Gisondi P, Melchi CF, Amerio P, Girolomoni G, Abeni D. Prevalence of symptoms experienced by patients with different clinical types of psoriasis. Br J Dermatol 2004; 151: 594-599.
15. Sampogna F, Sera F, Abeni D. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004; 122: 602-607.
16. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
17. Feldman SR, Fleischer AB, Jr. Reboussin DM, Rapp SR, Exum ML, Clark AR, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996; 106: 183-186.
18. Sampogna F, Sera F, Mazzotti E, Pasquini P, Picardi A, Abeni D. Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis. Arch Dermatol 2003; 139: 353-358; discussion 357.
19. Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 2002; 204: 43-49.
20. Goldberg D. The detection of psychiatric illness by questionnaire. London: Oxford University Press; 1972.
21. Picardi A, Abeni D, Mazzotti E, Fassone G, Lega I, Ramieri L, et al. Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire (GHQ-12). J Psychosom Res 2004; 57: 219-223.
22. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010; 146: 891-895.
23. Van Voorhees AS, Fried R. Depression and quality of life in psoriasis. Postgrad Med 2009; 121: 154-161.
24. Zachariae R, Zachariae C, Ibsen H, Mortensen JT, Wulf HC. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000; 80: 272-276.
25. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63.
26. Jones E, Farina A, Hastorf A, Markus H, Miller D. Social stigma: the psychology of marked relationships. New York: Freeman; 1984.
27. Fried RG, Friedman S, Paradis C, Hatch M, Lynfield Y, Duncanson C, et al. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995; 34: 101-105.
28. Young M. The psychological and social burdens of psoriasis. Dermatol Nurs 2005; 17: 15-19.
29. Miller TQ, Smith TW, Turner CW, Guijarro ML, Hallet AJ. A meta-analytic review of research on hostility and physical health. Psychol Bull 1996; 119: 322-348.
30. Koh KB, Kim CH, Park JK. Predominance of anger in depressive disorders compared with anxiety disorders and somatoform disorders. J Clin Psychiatry 2002; 63: 486-492.
31. Diong S-M, Bishop GD. Anger expression, coping styles, and well-being. J Health Psychol 1999; 4: 81-96.
32. Gupta MA, Gupta AK, Watteel GN. Early onset (<40 years age) psoriasis is comorbid with greater psychopathology than late onset psoriasis: a study of 137 patients. Acta Derm Venereol 1996; 76: 464-466.
33. Schmidt A, Rodrigues RS, Pipa CC, Brandalise LN, Lorenzi TM, Lara DR. Emotional and affective temperament in 23 professional areas. J Affect Disord 2010; 126: 49-54.
34. Fortune DG, Richards HL, Griffiths CE, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41: 157-174.
35. Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752-756.
36. Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol 2006; 154: 325-331.
37. Finzi A, Colombo D, Caputo A, Andreassi L, Chimenti S, Vena G, et al. Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol 2007; 21: 1161-1169.
38. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-284.
39. Wu Y, Mills D, Bala M. Impact of psoriasis on patients' work and productivity: a retrospective, matched case-control analysis. Am J Clin Dermatol 2009; 10: 407-410.